These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 26608630)

  • 1. Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.
    Pignatello R; Carbone C; Puglia C; Offerta A; Bonina FP; Puglisi G
    Ther Deliv; 2015; 6(11):1297-318. PubMed ID: 26608630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers.
    Gan L; Wang J; Jiang M; Bartlett H; Ouyang D; Eperjesi F; Liu J; Gan Y
    Drug Discov Today; 2013 Mar; 18(5-6):290-7. PubMed ID: 23092895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical and biomedical applications of lipid-based nanocarriers.
    Carbone C; Leonardi A; Cupri S; Puglisi G; Pignatello R
    Pharm Pat Anal; 2014 Mar; 3(2):199-215. PubMed ID: 24588596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanoparticles as drug/gene delivery systems to the retina.
    del Pozo-Rodríguez A; Delgado D; Gascón AR; Solinís MÁ
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):173-88. PubMed ID: 23286300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing lipid nanoparticles for topical ocular drug delivery.
    Alvarez-Trabado J; Diebold Y; Sanchez A
    Int J Pharm; 2017 Oct; 532(1):204-217. PubMed ID: 28893582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-Based Drug Delivery System: Recent Strategies for the Treatment of Ocular Disease and Future Perspective.
    Qamar Z; Qizilbash FF; Iqubal MK; Ali A; Narang JK; Ali J; Baboota S
    Recent Pat Drug Deliv Formul; 2019; 13(4):246-254. PubMed ID: 31884933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles.
    Leonardi A; Bucolo C; Romano GL; Platania CB; Drago F; Puglisi G; Pignatello R
    Int J Pharm; 2014 Aug; 470(1-2):133-40. PubMed ID: 24792979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
    Shree D; Patra CN; Sahoo BM
    Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid nanocarriers (LNC) and their applications in ocular drug delivery.
    Puglia C; Offerta A; Carbone C; Bonina F; Pignatello R; Puglisi G
    Curr Med Chem; 2015; 22(13):1589-602. PubMed ID: 25666802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancement of Lipid-Based Nanocarriers and Combination Application with Physical Penetration Technique.
    Yang M; Gu Y; Tang X; Wang T; Liu J
    Curr Drug Deliv; 2019; 16(4):312-324. PubMed ID: 30657039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in Ocular Drug Delivery, with Special Emphasis on Lipid Based Nanocarriers.
    Sah AK; Suresh PK
    Recent Pat Nanotechnol; 2015; 9(2):94-105. PubMed ID: 27009124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-based nanocarriers for the oral administration of biopharmaceutics.
    Karamanidou T; Bourganis V; Kammona O; Kiparissides C
    Nanomedicine (Lond); 2016 Nov; 11(22):3009-3032. PubMed ID: 27781558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II - Ocular drug-loaded lipid nanoparticles.
    Sánchez-López E; Espina M; Doktorovova S; Souto EB; García ML
    Eur J Pharm Biopharm; 2017 Jan; 110():58-69. PubMed ID: 27789359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutics and carriers: the dual role of proteins in nanoparticles for ocular delivery.
    Pescina S; Sonvico F; Santi P; Nicoli S
    Curr Top Med Chem; 2015; 15(4):369-85. PubMed ID: 25579343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles in Ocular Drug Delivery Systems for Topical Administration: Promises and Challenges.
    Almeida H; Amaral MH; Lobao P; Frigerio C; Sousa Lobo JM
    Curr Pharm Des; 2015; 21(36):5212-24. PubMed ID: 26412360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of drug safety by the use of lipid-based nanocarriers.
    Lim SB; Banerjee A; Önyüksel H
    J Control Release; 2012 Oct; 163(1):34-45. PubMed ID: 22698939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid lipid nanoparticles: promising therapeutic nanocarriers for drug delivery.
    Thukral DK; Dumoga S; Mishra AK
    Curr Drug Deliv; 2014; 11(6):771-91. PubMed ID: 25469779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-based nanocarriers for drug delivery and targeting: a patent survey of methods of production and characterization.
    Carbone C; Cupri S; Leonardi A; Puglisi G; Pignatello R
    Pharm Pat Anal; 2013 Sep; 2(5):665-77. PubMed ID: 24237173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
    Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
    Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: effect on skin permeation.
    Clares B; Calpena AC; Parra A; Abrego G; Alvarado H; Fangueiro JF; Souto EB
    Int J Pharm; 2014 Oct; 473(1-2):591-8. PubMed ID: 25102113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.